0001144204-18-064720.txt : 20181214
0001144204-18-064720.hdr.sgml : 20181214
20181214181424
ACCESSION NUMBER: 0001144204-18-064720
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181212
FILED AS OF DATE: 20181214
DATE AS OF CHANGE: 20181214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Rajeev M.
CENTRAL INDEX KEY: 0001619841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37926
FILM NUMBER: 181236583
MAIL ADDRESS:
STREET 1: C/O CIVITAS THERAPEUTICS, INC.
STREET 2: 190 EVERETT AVENUE
CITY: CHELSEA
STATE: MA
ZIP: 02150
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ra Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001481512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262908274
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617) 401-4060
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
tv509215_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-12-12
0
0001481512
Ra Pharmaceuticals, Inc.
RARX
0001619841
Shah Rajeev M.
C/O RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON
MA
02116
1
0
1
0
Common Stock
2018-12-14
4
P
0
1006452
15.50
A
4858260
I
See footnote
These securities include 836,666 shares held by RA Capital Healthcare Fund, L.P. (the "Fund") and 169,786 shares held in an account owned by a separately managed account (the "Account").
Represents 3,971,750 shares of Common Stock held by the Fund and 886,510 shares of Common Stock held in the Account.
RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser, and Mr. Shah is a managing director of the Adviser. Mr. Shah has no pecuniary interest in the reported securities held in the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by the Fund except to the extent of his pecuniary interest therein.
/s/ Rajeev Shah
2018-12-14